347597 <common-name>2-[[3-(4-chlorophenyl)-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]sulfanyl]-n-naphthalen-1-ylacetamide</common-name> <description>2-[[3-(4-chlorophenyl)-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]sulfanyl]-n-naphthalen-1-ylacetamide is a chemical compound with the formula C28H22ClN3O2S2. With an average molecular weight of 532.10 g/mol, 2-[[3-(4-chlorophenyl)-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]sulfanyl]-n-naphthalen-1-ylacetamide is a heavy molecule.</description> <cas>618432-09-0</cas> <pubchem-id>3867214</pubchem-id> <chemical-formula>C28H22ClN3O2S2</chemical-formula> <weight>532.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:22:54Z</created-at> <updated-at type="dateTime">2026-08-31T11:22:54Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CCC2=C(C1)C3=C(S2)N=C(N(C3=O)C4=CC=C(C=C4)Cl)SCC(=O)NC5=CC=CC6=CC=CC=C65</moldb-smiles> <moldb-formula>C28H22ClN3O2S2</moldb-formula> <moldb-inchi>InChI=1S/C28H22ClN3O2S2/c29-18-12-14-19(15-13-18)32-27(34)25-21-9-3-4-11-23(21)36-26(25)31-28(32)35-16-24(33)30-22-10-5-7-17-6-1-2-8-20(17)22/h1-2,5-8,10,12-15H,3-4,9,11,16H2,(H,30,33)</moldb-inchi> <moldb-inchikey>UNVKATLXJSFAPA-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">531.084197</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343490</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[3-(4-chlorophenyl)-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl]sulfanyl]-n-naphthalen-1-ylacetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Naphthalenes</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0297936</sync-id> <structure-inchikey>UNVKATLXJSFAPA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>600020000080000000080000000000200000004000008800400000000000000000022000000400004000208000000000100000000000000000008120000008000040000000000000000000002000001020000000000000001000000000000001008000000000000000000000000002010000000000000004000000080100000002000180008000000000008000000000010000008000000000000000000000000000000004000008114000000002000001000000000000200000000000000004000000000000000000000000001000800010000020020000000000000000c040000001000040000000000400000008010000008040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAKQAAAIABBgBgAAAAAgIGAGAAAAAC AgYAYAAAAAICBkAoAAAAAwQGQCgAAAADBAYAYAAAAAICBkAoAAAAAwQGQCgA AAADBBBAKAAAAAMCB0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQI ACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwERACAAAAABEAAgAAAAAgYAYAAAAAICBgAoAAAAAwQI ACgAAAADAgcAaAAAAAMCAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBo AAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgA AAADAwEGQCgAAAADBAsAAQABAgACAwADBGgMBAUABAZoDAYHaAwHCGgMBwlo DAkKaAwKC2gMCwxoDAwNKAILDiAOD2gMDxBoDBARaAwREmgMEhNoDBEUAAoV ABUWABYXABcYKAIXGSAZGiAaG2gMGxxoDBwdaAwdHmgMHh9oDB8gaAwgIWgM ISJoDCIjaAwFAAAIA2gMDAZoDBMOaAwjGmgMIx5oDEIGAAAABgAFBAMCAQUI BwYEAwYJCgsMBgcGDxAREhMOBhscHR4jGgYfICEiIx4XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:09Z</structure-indexed-at> </compound>